Soft Tissue Sarcoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Testing Ipilimumab and Nivolumab Combination With or Without Cabozantinib in People > = 18 Years Old With Advanced Soft Tissue Sarcoma
Conditions: Metastatic Extraskeletal Myxoid Chondrosarcoma; Metastatic Leiomyosarcoma; Metastatic Liposarcoma; Metastatic Undifferentiated Pleomorphic Sarcoma Interventions: Procedure: Biopsy; Procedure: Biospecimen Collection; Drug: Cabozantinib; Procedure: Computed Tomography; Biological: Ipilimumab; Procedure: Magnetic Resonance Imaging; Biological: Nivolumab Sponsor: National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 1, 2023 Category: Research Source Type: clinical trials